However, the centre’s director cautions there’s much work to be done before a COVID-19 vaccine could be approved for use
HALIFAX — The first Canadian clinical trials for a possible COVID-19 vaccine will be conducted by a Halifax research team that also was involved in trials that eventually led to a vaccine for the Ebola virus.
“The Phase 1 studies were done and within six months the data were available and the phase three studies were started in West Africa which then helped to actually stop the epidemic,” he said in an interview. Halperin pointed out that despite its early use during testing, the Ebola vaccine wasn’t actually licensed as a regular marketed vaccine until late last year.
Phase 1 will involve fewer than 100 healthy volunteers between the ages of 18 and 55 who will be followed over the next six months.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Halifax lab team to conduct first Canadian trials for possible COVID-19 vaccineHealth Canada has approved trials that will be conducted at the Canadian Centre for Vaccinology at Dalhousie University
Read more »
How the first Canadian COVID-19 vaccine trial will workThe first Canadian clinical trial of a potential COVID-19 vaccine will be fast-tracked, allowing it to potentially be completed in a much shorter time frame than the usual five to seven years.
Read more »
Ottawa pledges $100 million for Canadian Red Cross response to COVID-19, disastersThe Canadian Red Cross is poised to receive $100 million in federal funds to support public health measures and enhance the charity's capacity to respond to COVID-19, as well as future floods and wildfires.
Read more »
Health Canada approves first clinical trial for potential COVID-19 vaccineThe Canadian Center for Vaccinology at Dalhousie University will soon begin clinical trials of a potential COVID-19 vaccination, the first to be approved by Health Canada.
Read more »